A plethora of lifestyle-related chronic illnesses are sweeping the developed world, putting pressure on healthcare services and government spending.
Obesity, stroke, depression and diabetes are denting productivity, which is already suffering from a low birth rates and rising longevity. The question is, what innovations are institutional investors funding to get people back into work?
This is not just about developing a new bottle of pills; technology is playing a role with robotics and even AI influencing the next generation of healthcare products and services.
In April’s edition of portfolio institutional’s ESG Club we look at what the future of healthcare could look like.
